Literature DB >> 11102987

Polymorphisms in a pseudogene highly homologous to PMS2.

R B Chadwick1, J E Meek, T W Prior, P Peltomaki, A de La Chapelle.   

Abstract

PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3. Mutation of any of these DNA mismatch repair genes leads to impairment of DNA repair and can lead to tumorigenesis. Germline mutation of PMS2 has been reported as a rare cause of hereditary nonpolyposis colorectal cancer (HNPCC) and Turcot's syndrome. The PMS2 gene is located on chromosome 7p22 and consists of 15 exons. Within exon 11 of PMS2 is a coding repeat of eight adenosines. This study reports on the finding of a nonexpressed pseudogene that is highly homologous to the PMS2 gene in this region. The pseudogene is polymorphic for two alterations in the repeat region: a 3 bp delAAA at a site corresponding to nucleotide 1231 in PMS2; and an AA-->GG change at nucleotide 1238. Due to the high homology in both intronic and exonic sequences, polymorphisms in this pseudogene could be mistaken for mutations in the PMS2 gene and erroneously thought to be a cause of HNPCC and/or Turcot's syndrome. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102987     DOI: 10.1002/1098-1004(200012)16:6<530::AID-HUMU15>3.0.CO;2-6

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 2.  The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.

Authors:  C Richard Boland; Minoru Koi; Dong K Chang; John M Carethers
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

3.  MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

Authors:  Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2010-05-21       Impact factor: 2.857

4.  Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology.

Authors:  Madhuri Hegde; Sherri Bale; Pinar Bayrak-Toydemir; Jane Gibson; Linda Jo Bone Jeng; Loren Joseph; Jordan Laser; Ira M Lubin; Christine E Miller; Lainie F Ross; Paul G Rothberg; Alice K Tanner; Patrik Vitazka; Rong Mao
Journal:  J Mol Diagn       Date:  2015-02-12       Impact factor: 5.568

5.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

6.  Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.

Authors:  Felipe Carneiro da Silva; José Roberto de Oliveira Ferreira; Giovana Tardin Torrezan; Márcia Cristina Pena Figueiredo; Érika Maria Monteiro Santos; Wilson Toshihiko Nakagawa; Rafael Canfield Brianese; Ligia Petrolini de Oliveira; Maria Dirlei Begnani; Samuel Aguiar-Junior; Benedito Mauro Rossi; Fábio de Oliveira Ferreira; Dirce Maria Carraro
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

Review 7.  Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer.

Authors:  Camille Evrard; Gaëlle Tachon; Violaine Randrian; Lucie Karayan-Tapon; David Tougeron
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.